Second Genome Inc is categorized under Biological Products Manufacturers in South San Francisco, CA and active since 2010.
Second Genome Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Peter Dilaura at the company’s single location by writing to 349 Allerton Avenue, South San Francisco, California CA 94080 or by phoning (408) 718-0648. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Second Genome Inc |
| Contact Person: | Peter Dilaura |
| Address: | 349 Allerton Avenue, South San Francisco, California 94080 |
| Phone Number: | (408) 718-0648 |
| Website Address: | secondgenome.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Second Genome Inc was started in 2010 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Peter Dilaura for inquiries that concern Second Genome Inc by calling the company number (408) 718-0648, as your correspondence is most welcome. Additionally, the physical location of the single location of Second Genome Inc can be found at the coordinates as well as the street address 349 Allerton Avenue in South San Francisco, California 94080.
For its online presence, you may visit Second Genome Inc’s website at secondgenome.com and engage with its social media outlets through on Twitter and on Facebook.